1932
0
  1. Home
  2. A-Z Publications
  3. Annual Review of Public Health
  4. Volume 44, 2023
  5. Article

Annual Review of Public Health

Volume 44, 2023

Cancers Attributable to Modifiable Risk Factors: A Road Map for Prevention

Abstract

The implementation of primary and secondary preventive strategies is based on the evidence generated by cancer epidemiology, where the identification of risk factors and the description of their prevalence are fundamental to derive estimates on the burden of cancer from different etiologies, typically expressed as the population attributable fraction, which corresponds to the proportion of a cancer that may be prevented by controlling a given risk factor. However, even when cancer finds its etiology in modifiable factors, its prevention through the control of those factors is not always feasible, or it remains suboptimal despite the possibility of reducing the burden. We reviewed selected associations between modifiable risk factors and cancer, including tobacco smoking, occupational exposures, infections, air pollution, alcohol, and diet and obesity, and illustrated examples of both successes and failures in cancer control, underlying how current understanding of the avoidable causes of cancer is incomplete.

Keyword(s): attributable fraction, avoidable cancer, cancer control, modifiable factors, prevention, risk factors
Loading

Article metrics loading...

/content/journals/10.1146/annurev-publhealth-052220-124030
2023-04-03
2024-04-27
Loading full text...

Full text loading...

/deliver/fulltext/publhealth/44/1/annurev-publhealth-052220-124030.html?itemId=/content/journals/10.1146/annurev-publhealth-052220-124030&mimeType=html&fmt=ahah

Literature Cited

  1. 1.
    Abdel-Rahman O. 2018. Global trends in mortality from malignant mesothelioma: analysis of WHO mortality database (1994–2013). Clin. Respir. J. 12:2090–100
     [Google Scholar]
  2. 2.
    Agudo A, Ahrens W, Benhamou E, Benhamou S, Boffetta P et al. 2000. Lung cancer and cigarette smoking in women: a multicenter case-control study in Europe. Int. J. Cancer 88:820–27
     [Google Scholar]
  3. 3.
    Alavanja MCR, Ross MK, Bonner MR. 2013. Increased cancer burden among pesticide applicators and others due to pesticide exposure. CA Cancer J. Clin. 63:2120–42
     [Google Scholar]
  4. 4.
    Aune D, Lau R, Chan DSM, Vieira R, Greenwood DC et al. 2012. Dairy products and colorectal cancer risk: a systematic review and meta-analysis of cohort studies. Ann. Oncol. 23:37–45
     [Google Scholar]
  5. 5.
    Azevedo E Silva G, de Moura L, Curado MP, da Silva Gomes F, Otero U et al. 2016. The fraction of cancer attributable to ways of life, infections, occupation, and environmental agents in Brazil in 2020. PLOS ONE 11:e0148761
     [Google Scholar]
  6. 6.
    Bakhti SZ, Latifi-Navid S, Safaralizadeh R. 2020. Helicobacter pylori-related risk predictors of gastric cancer: the latest models, challenges, and future prospects. Cancer Med. 9:4808–22
     [Google Scholar]
  7. 7.
    Beasley RP, Hwang LY, Lin CC, Chien CS. 1981. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 2:1129–33
     [Google Scholar]
  8. 8.
    Boffetta P. 2004. Epidemiology of environmental and occupational cancer. Oncogene 23:6392–403
     [Google Scholar]
  9. 9.
    Boffetta P, Donato F, Pira E, Luu HN, La Vecchia C. 2019. Risk of mesothelioma after cessation of asbestos exposure: a systematic review and meta-regression. Int. Arch. Occup. Environ. Health 92:949–57
     [Google Scholar]
  10. 10.
    Boffetta P, La Vecchia C, Moolgavkar S 2015. Chronic effects of air pollution are probably overestimated. Risk Anal. 35:766–69
     [Google Scholar]
  11. 11.
    Boffetta P, Malvezzi M, Pira E, Negri E, La Vecchia C. 2018. International analysis of age-specific mortality rates from mesothelioma on the basis of the International Classification of Diseases, 10th Revision. J. Glob. Oncol. 4:1–15
     [Google Scholar]
  12. 12.
    Boffetta P, Tubiana M, Hill C, Boniol M, Aurengo A et al. 2009. The causes of cancer in France. Ann. Oncol. 20:550–55
     [Google Scholar]
  13. 13.
    Bornschein J, Bird-Lieberman EL, Malfertheiner P 2019. The rationale and efficacy of primary and secondary prevention in adenocarcinomas of the upper gastrointestinal tract. Dig. Dis. 37:381–93
     [Google Scholar]
  14. 14.
    Bosetti C, Bertuccio P, Levi F, Lucchini F, Negri E, La Vecchia C. 2008. Cancer mortality in the European Union, 1970–2003, with a joinpoint analysis. Ann. Oncol. 19:631–40
     [Google Scholar]
  15. 15.
    Bradbury KE, Murphy N, Key TJ. 2020. Diet and colorectal cancer in UK Biobank: a prospective study. Int. J. Epidemiol. 49:246–58
     [Google Scholar]
  16. 16.
    Bray F, Colombet M, Mery L, Piñeros M, Znaor A et al., eds. 2017. Cancer Incidence in Five Continents, Vol. XI Lyon: Int. Agency Res. Cancer (IARC). Electron. Version http://ci5.iarc.fr
  17. 17.
    Brown KF, Rumgay H, Dunlop C, Ryan M, Quartly F et al. 2018. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. Br. J. Cancer 118:1130–41
     [Google Scholar]
  18. 18.
    Brown LM. 2000. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol. Rev. 22:283–97
     [Google Scholar]
  19. 19.
    Burnett R, Chen H, Szyszkowicz M, Fann N, Hubbell B et al. 2018. Global estimates of mortality associated with long-term exposure to outdoor fine particulate matter. PNAS 115:9592–97
     [Google Scholar]
  20. 20.
    Cai Q, Zhu C, Yuan Y, Feng Q, Hao Y et al. 2019. Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study. Gut 68:1576–87
     [Google Scholar]
  21. 21.
    Cândido FG, Valente FX, Grześkowiak ŁM, Boroni Moreira AP, Mayumi Usuda Prado Rocha D, de Cássia Gonçalves Alfenas R 2018. Impact of dietary fat on gut microbiota and low-grade systemic inflammation: mechanisms and clinical implications on obesity. Int. J. Food Sci. Nutr. 69:125–43
     [Google Scholar]
  22. 22.
    Carbone M, Adusumilli PS, Alexander HR Jr., Baas P, Bardelli F et al. 2019. Mesothelioma: scientific clues for prevention, diagnosis, and therapy. CA Cancer J. Clin. 69:402–29
     [Google Scholar]
  23. 23.
    Chang M-H, You S-L, Chen C-J, Liu C-J, Lai M-W et al. 2016. Long-term effects of hepatitis B immunization of infants in preventing liver cancer. Gastroenterology 151:472–80.e1
     [Google Scholar]
  24. 24.
    Chang M-H, You S-L, Chen C-J, Liu C-J, Lee C-M et al. 2009. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J. Natl. Cancer Inst. 101:1348–55
     [Google Scholar]
  25. 25.
    Chen MS Jr., Dang JH. 2017. What might we learn from the more successful uptake of hepatitis B (HBV) vaccinations to increase human papillomavirus (HPV) vaccinations in adolescents?. Vaccine 35:3801–2
     [Google Scholar]
  26. 26.
    Cheung K, Shafer MM, Schauer JJ, Sioutas C. 2012. Historical trends in the mass and chemical species concentrations of coarse particulate matter in the Los Angeles Basin and relation to sources and air quality regulations. J. Air Waste Manag. Assoc. 62:541–56
     [Google Scholar]
  27. 27.
    Choi IJ, Kim CG, Lee JY, Kim Y-I, Kook M-C et al. 2020. Family history of gastric cancer and Helicobacter pylori treatment. N. Engl. J. Med. 382:427–36
     [Google Scholar]
  28. 28.
    Ciabattini M, Rizzello E, Lucaroni F, Palombi L, Boffetta P. 2021. Systematic review and meta-analysis of recent high-quality studies on exposure to particulate matter and risk of lung cancer. Environ. Res. 196:110440
     [Google Scholar]
  29. 29.
    Ciocan C, Godono A, Franco N, La Vecchia C, Negri E et al. 2022. Mortality from bladder cancer in dyestuff workers exposed to aromatic amines: a 73-year follow-up. Med. Lav. 113:e2022017
     [Google Scholar]
  30. 30.
    Cogliano VJ, Baan R, Straif K, Gross Y, Lauby-Secretan B et al. 2011. Preventable exposures associated with human cancers. J. Natl. Cancer Inst. 103:1827–39
     [Google Scholar]
  31. 31.
    Collatuzzo G, Fiorini G, Vaira B, Violante FS, Farioli A, Boffetta P. 2021. The role of the occupational physician in controlling gastric cancer attributable to Helicobacter pylori infection: a review. Prev. Med. Rep. 24:101527
     [Google Scholar]
  32. 32.
    Collatuzzo G, Pelucchi C, Negri E et al. 2021. Exploring the interactions between Helicobacter pylori (Hp) infection and other risk factors of gastric cancer: a pooled analysis in the Stomach cancer Pooling (StoP) Project. Int. J. Cancer 149:1228–38
     [Google Scholar]
  33. 33.
    Correa P, Houghton J. 2007. Carcinogenesis of Helicobacter pylori. Gastroenterology 133:659–72
     [Google Scholar]
  34. 34.
    de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. 2020. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob. Health 8:e180–90
     [Google Scholar]
  35. 35.
    Doll R, Peto R. 1981. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst. 66:1191–308
     [Google Scholar]
  36. 36.
    Doll R, Peto R, Boreham J, Sutherland I. 2004. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ 328:1519
     [Google Scholar]
  37. 37.
    Ferrari P, McKay JD, Jenab M, Brennan P, Canzian F et al. 2012. Alcohol dehydrogenase and aldehyde dehydrogenase gene polymorphisms, alcohol intake and the risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition study. Eur. J. Clin. Nutr. 66:1303–8
     [Google Scholar]
  38. 38.
    Flor LS, Reitsma MB, Gupta V, Ng M, Gakidou E. 2021. The effects of tobacco control policies on global smoking prevalence. Nat. Med. 27:239–43
     [Google Scholar]
  39. 39.
    Fuccio L, Zagari RM, Eusebi LH, Laterza L, Cennamo V et al. 2009. Meta-analysis: Can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?. Ann. Intern. Med. 151:121–28
     [Google Scholar]
  40. 40.
    Fukase K, Kato M, Kikuchi S et al. 2008. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 372:392–97
     [Google Scholar]
  41. 41.
    GBD 2019 Respir. Tract Cancers Collab 2021. Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Respir. Med. 9:1030–49
     [Google Scholar]
  42. 42.
    Grazzini M, Arcangeli G, Mucci N, Bonanni P, Bini C et al. 2020. High chance to overcome the non-responder status to hepatitis B vaccine after a further full vaccination course: results from the extended study on healthcare students and workers in Florence, Italy. Hum. Vaccin. Immunother. 16:949–54
     [Google Scholar]
  43. 43.
    Gu KJ, Li G. 2020. An overview of cancer prevention: chemoprevention and immunoprevention. J. Cancer Prev. 25:127–35
     [Google Scholar]
  44. 44.
    Hepat. B Found 2020. Vaccine schedules. Prevention & Diagnosis https://www.hepb.org/prevention-and-diagnosis/vaccination/guidelines-2/
    [Google Scholar]
  45. 45.
    Howson CP, Hiyama T, Wynder EL. 1986. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol. Rev. 8:1–27
     [Google Scholar]
  46. 46.
    IARC Helicobacter pylori Work. Group 2014. Helicobacter pylori eradication as a strategy for preventing gastric cancer, Vol. 8 IARC Work. Group Rep., Int. Agency Res. Cancer Lyon, Fr.: https://www.gastro-health-now.org/wp/wp-content/uploads/2014/09/WHO-IARC-Report-2014.pdf
    [Google Scholar]
  47. 47.
    IARC (Int. Agency Res. Cancer) 2004. Tobacco Smoke and Involuntary Smoking IARC Monogr. Eval. Carcinog. Risks Hum . Vol. 83 Lyon: IARC
  48. 48.
    IARC (Int. Agency Res. Cancer) 2012. Biological Agents IARC Monogr. Eval. Carcinog. Risks Hum. Vol. 100B Lyon: IARC
  49. 49.
    IARC (Int. Agency Res. Cancer) 2015. Outdoor Air Pollution IARC Monogr. Eval. Carcinog. Risks Hum . Vol. 109 Lyon: IARC
  50. 50.
    India State-Level Dis. Burden Initiat. Air Pollut. Collab 2021. Health and economic impact of air pollution in the states of India: the Global Burden of Disease Study 2019. Lancet Planet. Health 5:e25–38
     [Google Scholar]
  51. 51.
    Iscovich JM, Parkin DM. 1996. The risk of cancer in three generations of young Israelis: a study of migrants and their descendants IARC Tech. Rep. 27 Int. Agency Res. Cancer Lyon, Fr.:
  52. 52.
    Islami F, Goding Sauer A, Miller KD, Siegel RL, Fedewa SA et al. 2018. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J. Clin. 68:31–54
     [Google Scholar]
  53. 53.
    Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M et al. 2013. 21st-century hazards of smoking and benefits of cessation in the United States. N. Engl. J. Med. 368:341–50
     [Google Scholar]
  54. 54.
    Jin G, Lv J, Yang M, Wang M, Zhu M et al. 2020. Genetic risk, incident gastric cancer, and healthy lifestyle: a meta-analysis of genome-wide association studies and prospective cohort study. Lancet Oncol. 21:1378–86
     [Google Scholar]
  55. 55.
    Kamat AM, Hahn NM, Efstathiou JA, Lerner SP, Malström P-U et al. 2016. Bladder cancer. Lancet 388:2796–810
     [Google Scholar]
  56. 56.
    Kato M, Ota H, Okuda M, Kikuchi S, Satoh K et al. 2019. Guidelines for the management of Helicobacter pylori infection in Japan: 2016 revised edition. Helicobacter 24:e12597
     [Google Scholar]
  57. 57.
    Kolonel LN, Wilkens LR 2006. Migrant studies. Cancer Epidemiology and Prevention D Schottenfeld, JF Fraumeni Jr. 189–201. New York: Oxford Univ. Press
     [Google Scholar]
  58. 58.
    Kulik L, El-Serag HB. 2019. Epidemiology and management of hepatocellular carcinoma. Gastroenterology 156:477–91
     [Google Scholar]
  59. 59.
    La Vecchia C, Bosetti C, Lucchini F, Bertuccio P, Negri E et al. 2010. Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975. Ann. Oncol. 21:1323–60
     [Google Scholar]
  60. 60.
    La Vecchia C, Negri E, Carioli G 2022. Progress in cancer epidemiology: avoided deaths in Europe over the last three decades. Eur. J. Cancer Prev. 31:388–92
     [Google Scholar]
  61. 61.
    Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F et al. 2016. Body fatness and cancer—viewpoint of the IARC Working Group. N. Engl. J. Med. 375:794–98
     [Google Scholar]
  62. 62.
    Lemen RA, Landrigan PJ. 2017. Toward an asbestos ban in the United States. Int. J. Environ. Res. Public Health 14:1302
     [Google Scholar]
  63. 63.
    Lin C-L, Kao J-H. 2018. Review article: the prevention of hepatitis B-related hepatocellular carcinoma. Aliment. Pharmacol. Ther. 48:5–14
     [Google Scholar]
  64. 64.
    Liu X, Jiang J, Yu C, Wang Y, Sun Y et al. 2019. Secular trends in incidence and mortality of bladder cancer in China, 1990–2017: a joinpoint and age-period-cohort analysis. Cancer Epidemiol. 61:95–103
     [Google Scholar]
  65. 65.
    Malaty HM, El-Kasabany A, Graham DY, Miller CC, Reddy SG et al. 2002. Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet 359:931–35
     [Google Scholar]
  66. 66.
    Malfertheiner P, Megraud F, O'Morain CA, Gisbert JP, Kuipers EJ et al. 2017. Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report. Gut 66:6–30
     [Google Scholar]
  67. 67.
    Malvezzi M, Bosetti C, Rosso T, Bertuccio P, Chatenoud L et al. 2013. Lung cancer mortality in European men: trends and predictions. Lung Cancer 80:138–45
     [Google Scholar]
  68. 68.
    Méndez D, Alshanqeety O, Warner KE. 2013. The potential impact of smoking control policies on future global smoking trends. Tob. Control 22:46–51
     [Google Scholar]
  69. 69.
    Montalban C, Santon A, Boixeda D, Bellas C. 2001. Regression of gastric high grade mucosa associated lymphoid tissue (MALT) lymphoma after Helicobacter pylori eradication. Gut 49:584–87
     [Google Scholar]
  70. 70.
    Morton LM, Slager SL, Cerhan JR, Wang SS, Vajdic CM et al. 2014. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J. Natl. Cancer Inst. Monogr. 2014:48130–44
     [Google Scholar]
  71. 71.
    Nakamura S, Sugiyama T, Matsumoto T, Iijima K, Ono S et al. 2012. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan. Gut 61:507–13
     [Google Scholar]
  72. 72.
    Natl. Immun. Progr., CDC (Cent. Dis. Control Prev.) 2002. Achievements in public health: hepatitis B vaccination—United States, 1982–2002. MMWR 51:549–52, 563
    [Google Scholar]
  73. 73.
    Negri E, La Vecchia C, Bruzzi P, Dardanoni G, Decarli A et al. 1988. Risk factors for breast cancer: pooled results from three Italian case-control studies. Am. J. Epidemiol. 128:1207–15
     [Google Scholar]
  74. 74.
    Neumann H-G. 2010. Aromatic amines: mechanisms of carcinogenesis and implications for risk assessment. Front. Biosci. 15:1119–30
     [Google Scholar]
  75. 75.
    O'Keefe SJD. 2016. Diet, microorganisms and their metabolites, and colon cancer. Nat. Rev. Gastroenterol. Hepatol. 13:691–706
     [Google Scholar]
  76. 76.
    Okuda M, Lin Y, Kikuchi S. 2019. Helicobacter pylori infection in children and adolescents. Adv. Exp. Med. Biol. 1149:107–20
     [Google Scholar]
  77. 77.
    Pan K-F, Zhang L, Gerhard M, Ma J-L, Liu W-D et al. 2016. A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication. Gut 65:9–18
     [Google Scholar]
  78. 78.
    Park S-K, Jung H-Y, Kim DH, Kim M-Y, Lee JH et al. 2012. Regression of advanced gastric MALT lymphoma after the eradication of Helicobacter pylori. Gut Liver 6:270–74
     [Google Scholar]
  79. 79.
    Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R 2000. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case–control studies. BMJ 321:323–29
     [Google Scholar]
  80. 80.
    Pira E, Piolatto G, Negri E, Romano C, Boffetta P et al. 2010. Bladder cancer mortality of workers exposed to aromatic amines: a 58-year follow-up. J. Natl. Cancer Inst. 102:1096–99
     [Google Scholar]
  81. 81.
    Pirie K, Peto R, Reeves GK, Green J, Beral V, Million Women Study Collab 2013. The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet 381:133–41
     [Google Scholar]
  82. 82.
    Poole C. 2015. A history of the population attributable fraction and related measures. Ann. Epidemiol. 25:147–54
     [Google Scholar]
  83. 83.
    Pukkala E, Martinsen JI, Lynge E, Gunnarsdottir HK, Sparén P et al. 2009. Occupation and cancer—follow-up of 15 million people in five Nordic countries. Acta Oncol. 48:646–790
     [Google Scholar]
  84. 84.
    Purdue MP, Hutchings SJ, Rushton L, Silverman DT. 2015. The proportion of cancer attributable to occupational exposures. Ann. Epidemiol. 25:188–92
     [Google Scholar]
  85. 85.
    Puzzono M, Mannucci A, Grannò S, Zuppardo RA, Galli A et al. 2021. The role of diet and lifestyle in early-onset colorectal cancer: a systematic review. Cancers 13:5933
     [Google Scholar]
  86. 86.
    Qiu L, Qu X, He J, Cheng L, Zhang R et al. 2020. Predictive model for risk of gastric cancer using genetic variants from genome-wide association studies and high-evidence meta-analysis. Cancer Med. 9:7310–16
     [Google Scholar]
  87. 87.
    Rake C, Gilham C, Hatch J, Darnton A, Hodgson J, Peto J. 2009. Occupational, domestic and environmental mesothelioma risks in the British population: a case-control study. Br. J. Cancer 100:1175–83
     [Google Scholar]
  88. 88.
    Rebbeck TR. 2017. Prostate cancer genetics: variation by race, ethnicity, and geography. Semin. Radiat. Oncol. 27:3–10
     [Google Scholar]
  89. 89.
    Rokkas T, Gisbert JP, Malfertheiner P, Niv Y, Gasbarrini A et al. 2021. Comparative effectiveness of multiple different first-line treatment regimens for Helicobacter pylori infection: a network meta-analysis. Gastroenterology 161:495–507
     [Google Scholar]
  90. 90.
    Schillie S, Vellozzi C, Reingold A, Harris A, Haber P et al. 2018. Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm. Rep. 67:1–31
     [Google Scholar]
  91. 91.
    Seidman H, Selikoff IJ, Gelb SK. 1986. Mortality experience of amosite asbestos factory workers: dose-response relationships 5 to 40 years after onset of short-term work exposure. Am. J. Ind. Med. 10:479–514
     [Google Scholar]
  92. 92.
    Shi J-F, Cao M, Wang Y, Bai F-Z, Lei L et al. 2021. Is it possible to halve the incidence of liver cancer in China by 2050?. Int. J. Cancer 148:1051–65
     [Google Scholar]
  93. 93.
    Shield KD, Parkin DM, Whiteman DC, Rehm J, Viallon V et al. 2016. Population attributable and preventable fractions: cancer risk factor surveillance, and cancer policy projection. Curr. Epidemiol. Rep. 3:201–11
     [Google Scholar]
  94. 94.
    Smith KR. 2000. National burden of disease in India from indoor air pollution. PNAS 97:13286–93
     [Google Scholar]
  95. 95.
    Smith-Sivertsen T, Díaz E, Pope D, Lie RT, Díaz A et al. 2009. Effect of reducing indoor air pollution on women's respiratory symptoms and lung function: the RESPIRE Randomized Trial, Guatemala. Am. J. Epidemiol. 170:211–20
     [Google Scholar]
  96. 96.
    Song M, Chan AT, Sun J. 2020. Influence of the gut microbiome, diet, and environment on risk of colorectal cancer. Gastroenterology 158:322–40
     [Google Scholar]
  97. 97.
    Stubljar D, Jukic T, Ihan A. 2018. How far are we from vaccination against Helicobacter pylori infection?. Expert Rev. Vaccines 17:935–45
     [Google Scholar]
  98. 98.
    Sugano K, Tack J, Kuipers EJ, Graham DY, El-Omar EM et al. 2015. Kyoto global consensus report on Helicobacter pylori gastritis. Gut 64:1353–67
     [Google Scholar]
  99. 99.
    Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I et al. 2021. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71:209–49
     [Google Scholar]
  100. 100.
    Sung H, Siegel RL, Torre LA, Pearson-Stuttard J, Islami F et al. 2019. Global patterns in excess body weight and the associated cancer burden. CA Cancer J. Clin. 69:88–112
     [Google Scholar]
  101. 101.
    Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA et al., eds. 2017. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Lyon, Fr.: Int. Agency Res. Cancer (IARC). Revis. , 4th ed..
  102. 102.
    Terasawa T, Nishida H, Kato K, Miyashiro I, Yoshikawa T et al. 2014. Prediction of gastric cancer development by serum pepsinogen test and Helicobacter pylori seropositivity in Eastern Asians: a systematic review and meta-analysis. PLOS ONE 9:e109783
     [Google Scholar]
  103. 103.
    Thanikachalam K, Khan G. 2019. Colorectal cancer and nutrition. Nutrients 11:164
     [Google Scholar]
  104. 104.
    Thomas T. 2021. Genetic risk score predicts prostate cancer incidence and mortality. Nat. Rev. Urol. 18:72
     [Google Scholar]
  105. 105.
    Thrift AP, El-Serag HB. 2020. Burden of gastric cancer. Clin. Gastroenterol. Hepatol. 18:534–42
     [Google Scholar]
  106. 106.
    Tomasetti C, Li L, Vogelstein B. 2017. Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention. Science 355:1330–34
     [Google Scholar]
  107. 107.
    Uddin R, Lee E-Y, Khan SR, Tremblay MS, Khan A. 2020. Clustering of lifestyle risk factors for non-communicable diseases in 304,779 adolescents from 89 countries: a global perspective. Prev. Med. 131:105955
     [Google Scholar]
  108. 108.
    Vanagunas A. 1997. Eradication of Helicobacter pylori and regression of B-cell lymphoma. Biomed. Pharmacother. 51:156–60
     [Google Scholar]
  109. 109.
    Vermeulen R, Schymanski EL, Barabási A-L, Miller GW. 2020. The exposome and health: where chemistry meets biology. Science 367:392–96
     [Google Scholar]
  110. 110.
    Vieira AR, Abar L, Chan DSM, Vingeliene S, Polemiti E et al. 2017. Foods and beverages and colorectal cancer risk: a systematic review and meta-analysis of cohort studies, an update of the evidence of the WCRF-AICR Continuous Update Project. Ann. Oncol. 28:1788–802
     [Google Scholar]
  111. 111.
    Vineis P, Simonato L. 1991. Proportion of lung and bladder cancers in males resulting from occupation: a systematic approach. Arch. Environ. Health 46:6–15
     [Google Scholar]
  112. 112.
    Vineis P, Wild CP. 2014. Global cancer patterns: causes and prevention. Lancet 383:549–57
     [Google Scholar]
  113. 113.
    Wang JB, Jiang Y, Liang H, Li P, Xiao HJ et al. 2012. Attributable causes of cancer in China. Ann. Oncol. 23:2983–89
     [Google Scholar]
  114. 114.
    WCRF (World Cancer Res. Fund)/Am. Inst. Cancer Res 2018. Continuous Update Project: diet, nutrition, physical activity and the prevention of cancer. Summary of strong evidence Rep. WCRF London: https://wcrf.org/cupmatrix
    [Google Scholar]
  115. 115.
    WHO (World Health Organiz.) 2016. Global health sector strategy on viral hepatitis 2016–2021 Rep. WHO Geneva: http://apps.who.int/iris/bitstream/handle/10665/246177/WHO-HIV-2016.06-eng.pdf?sequence=1
    [Google Scholar]
  116. 116.
    WHO (World Health Organiz.) 2017. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics Rep. WHO Geneva:
  117. 117.
    Willett WC. 2012. Nutritional Epidemiology New York: Oxford Univ. Press. , 3rd ed..
  118. 118.
    Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A et al. 1993. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342:575–77
     [Google Scholar]
  119. 119.
    Zagari RM, Frazzoni L, Marasco G, Fuccio L, Bazzoli F. 2021. Treatment of Helicobacter pylori infection: a clinical practice update. Minerva Med. 112:2281–87
     [Google Scholar]
  120. 120.
    Zeng M, Mao X-H, Li J-X, Tong W-D, Wang B et al. 2015. Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 386:1457–64
     [Google Scholar]
  121. 121.
    Zheng W, McLerran DF, Rolland B, Zhang X, Inoue M et al. 2011. Association between body-mass index and risk of death in more than 1 million Asians. N. Engl. J. Med. 364:719–29
     [Google Scholar]
/content/journals/10.1146/annurev-publhealth-052220-124030
Loading
Cancers Attributable to Modifiable Risk Factors: A Road Map for Prevention
Annual Review of Public Health 44, 279 (2023); https://doi.org/10.1146/annurev-publhealth-052220-124030
/content/journals/10.1146/annurev-publhealth-052220-124030
/content/journals/10.1146/annurev-publhealth-052220-124030
Loading

Data & Media loading...

Supplemental Material

Supplementary Data

  • Article Type: Review Article

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error